- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Intrahepatic Cholangiocarcinoma
Total 6765 results
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Incyte CorporationActive, not recruitingAdvanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Gastrointestinal (GI) MalignanciesUnited States, Netherlands, Spain, United Kingdom, Belgium, Austria
-
M.D. Anderson Cancer CenterTelix Pharmaceuticals LimitedActive, not recruitingClear Cell Renal Cell Carcinoma | Advanced CancerUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States, Israel, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Spain, Sweden, Ta... and more
-
Helsinn Healthcare SALabcorp Drug Development IncWithdrawnAdvanced Solid Tumor | CNS Tumor | Recurrent WHO Grade II GliomaUnited States, Canada, Germany
-
Philogen S.p.A.CompletedAdvanced Solid Tumors Amenable to Anthracycline Therapy | Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline TherapyGermany, Italy
-
Eli Lilly and CompanyTerminatedColorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid TumorUnited States, Australia
-
Shanghai Junshi Bioscience Co., Ltd.UnknownAdvanced Melanoma | Kidney Cancer Stage IvChina
-
Assiut UniversityCompletedAdvanced Parkinson's With DysphagiaEgypt
-
Incyte CorporationTerminatedBreast Cancer | Pancreatic Cancer | Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Advanced Cancer | NHL (Non-Hodgkin Lymphoma) | UC (Ureter and Urethera)United States
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Bristol-Myers SquibbCompletedSoft Tissue Sarcoma | Transitional Cell Carcinoma | Advanced Non-small Cell Lung Cancer | Gastric/Esophageal Adenocarcinoma | Pancreatic Cancer Including Ampulla of VaterUnited States, Argentina, Germany, Belgium, Canada, Poland, Netherlands, United Kingdom, France
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Hyunseok Kang, MDNRG OncologyCompletedClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IV Hypopharyngeal... and other conditionsUnited States
-
Osel, Inc.City of Hope Comprehensive Cancer Center; Miyarisan Pharmaceutical Co., Ltd.RecruitingAdvanced or Metastatic Renal Cell CarcinomaUnited States
-
Ruijin HospitalChongqing Kingbiotech Co.,LtdRecruitingAdvanced Pancreatic Neuroendocrine TumorChina
-
Xuesong LiRecruitingUrothelial Carcinoma Ureter | Locally AdvancedChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Endometrial Cancer | Sarcoma of UterusChina
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingUterine Carcinosarcoma | Advanced Uterine CarcinosarcomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMycosis Fungoides | Sezary Syndrome | Mycosis Fungoides/Sezary Syndrome | Sézary | Advanced Mycosis FungoidesUnited States
-
IpsenRecruitingAdvanced or Metastatic Renal Cell CarcinomaBelgium
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingAdvanced Non-Clear Cell Kidney CancerUnited States
-
Shanghai Junshi Bioscience Co., Ltd.CompletedAdvanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic ChemotherapyChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage III Pancreatic Cancer AJCC v8 | Borderline Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal AdenocarcinomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Chordoma and Alveolar Soft Part SarcomaUnited States, Taiwan, Spain, Canada, Singapore, Italy, Japan, Israel, France
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic AdenocarcinomaUnited States, Israel, Canada
-
Orion Corporation, Orion PharmaCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticFinland, France, Denmark
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre LaboratoriesActive, not recruitingBreast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid TumoursFrance
-
Syros PharmaceuticalsCompletedBreast Cancer | Pancreatic Cancer | Advanced Solid Tumor | Small-cell Lung CancerUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Lung Carcinoma | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8United States
-
Ohio State University Comprehensive Cancer CenterCompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Primary Peritoneal Cancer | Advanced Solid TumoursAustralia
-
M.D. Anderson Cancer CenterCompletedAdenocarcinoma | Cervical Cancer | Cervical Squamous Cell Carcinoma | Locally Advanced Malignant Neoplasm | Adenosquamous CarcinomaUnited States, Belgium
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage I Colon Cancer | Stage II Colon Cancer | Stage III Colon Cancer | Adenocarcinoma of the Colon | Advanced Colorectal AdenomasUnited States
-
EASL - CLIF ConsortiumTerminatedPneumonia | Cholangitis | Advanced Chronic Liver Disease | Urinary Infection | Other Bacterial DiseasesSpain
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
AmgenCompletedColorectal Cancer | Non-Small Cell Lung Cancer | Prostate Cancer | Solid Tumors | Advanced Renal Cell Carcinoma
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Advanced Malignant Solid Neoplasm | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Ductal AdenocarcinomaUnited States
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Bristol-Myers SquibbRecruitingAdvanced Renal Cell Carcinoma (aRCC)United States
-
TheRas, Inc., d/b/a BridgeBio Oncology TherapeuticsRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
Michael B. Atkins, MDGeorgetown University; Agenus Inc.RecruitingAdvanced Renal Cell CarcinomaUnited States
-
First Affiliated Hospital of Guangxi Medical UniversityZhejiang Cancer Hospital; Guilin Medical University, China; Liuzhou Workers Hospital and other collaboratorsNot yet recruitingLocally Advanced Nasopharyngeal Carcinoma